Effects of Novel Anti-VEGF Agents with Intravitreal Conbercept in Diabetic Retinopathy: A Systematic Review and Meta-Analysis

Effects of Novel Anti-VEGF Agents with Intravitreal Conbercept in Diabetic Retinopathy: A Systematic Review and Meta-Analysis

To evaluate the efficacy and safety of intravitreal conbercept (IVC) for diabetic retinopathy (DR) compared with intravitreal triamcinolone acetonide (IVTA). PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure, VIP database, and Wanfang database were searched from their earlies...

Full description

Bibliographic Details
Main Authors:	Hui Wang, Jing Zhou, Caoyu Sun, Xu Dong
Format:	Article
Language:	English
Published:	Hindawi Limited 2021-01-01
Series:	Evidence-Based Complementary and Alternative Medicine
Online Access:	http://dx.doi.org/10.1155/2021/9357108

Similar Items

Systematic evaluation of the effectiveness and safety of intravitreal injection of Conbercept for diabetic retinopathy
by: Chun-Xing Li, et al.
Published: (2018-10-01)

Effects of vitrectomy with preoperative intravitreal Conbercept for proliferative diabetic retinopathy
by: Huai-Sheng Zhou, et al.
Published: (2018-02-01)

Intravitreal injection of Conbercept combined with PPV in the treatment of proliferative diabetic retinopathy
by: Zhou Ou, et al.
Published: (2021-06-01)

Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy
by: Jian-Bo Mao, et al.
Published: (2018-07-01)

A Systematic Review and Meta-Analysis of Clinical Outcomes of Intravitreal Anti-VEGF Agent Treatment Immediately after Cataract Surgery for Patients with Diabetic Retinopathy
by: Li-Quan Zhao, et al.
Published: (2019-01-01)

A lower dose of intravitreal conbercept effectively treats retinopathy of prematurity
by: Yong Cheng, et al.
Published: (2018-07-01)

Preoperative Intravitreal Conbercept Facilitates Vitrectomy in Proliferative Diabetic Retinopathy: Is Attention Required for the Fellow Eye?
by: Wei Xu, et al.
Published: (2019-01-01)

Difference in the Vitreal Protein Profiles of Patients with Proliferative Diabetic Retinopathy with and without Intravitreal Conbercept Injection
by: Chen Zou, et al.
Published: (2018-01-01)

Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy
by: Jinglin Cui, et al.
Published: (2018-01-01)

Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections
by: Levin AM, et al.
Published: (2017-01-01)

Comparison of the Efficacy and Safety of Intravitreal Conbercept with Intravitreal Ranibizumab for Treatment of Diabetic Macular Edema: A Meta-Analysis
by: Xiaolei Sun, et al.
Published: (2020-01-01)

Clinical effect of 25G+ vitrectomy combined with intravitreal injection of Conbercept in the treatment of severe proliferative diabetic retinopathy
by: Yong-Mou Zhou, et al.
Published: (2017-12-01)

Intravitreal anti-VEGF inhibition in a pre-operative proliferative diabetic retinopathy setting
by: Andreia Sofia Moreira Teixeira
Published: (2019)

Correlation between responses to intravitreal injection of anti-VEGF and diabetic retinopathy extent in diabetic macular edema patients
by: Yue Huang, et al.
Published: (2017-02-01)

Use of intravitreal anti-VEGF: Retinopathy of prematurity surgeons′ in Hamlet′s dilemma?
by: Rajvardhan Azad
Published: (2011-01-01)

Efficacy of intravitreal injection of Conbercept in the treatment of diabetic macular edema
by: Chen Jiang, et al.
Published: (2018-02-01)

Clinical observation of intravitreal injection of Conbercept treating diabetic macularedema
by: Li Jiang, et al.
Published: (2017-06-01)

Effect of intravitreal injection of Conbercept with laser photocoagulation on diabetic macular edema
by: Qiu-Xia Li, et al.
Published: (2018-06-01)

Intravitreal injection of Conbercept-assisted vitrectomy for the treatment of proliferative diabetic retinopathy and its effects on inflammatory factors and ANGPTL4 in the vitreous
by: Si-Hua Cheng, et al.
Published: (2019-12-01)

Evaluation of RNFL thickness and serum cytokine levels after retinal photocoagulation combined with intravitreous Conbercept injection treatment of diabetic retinopathy
by: Luo Na
Published: (2016-08-01)

Influencing factors of diabetic retinopathy in patients with diabetes mellitus and therapeutic effect of Conbercept
by: Yan Zhou, et al.
Published: (2020-04-01)

Intravitreal injection of conbercept combined with triamcinolone acetonide for diabetic macular edema
by: Jun Li<sup>*</sup>, et al.
Published: (2019-03-01)

Fluorescein Angiographic Findings of Peripheral Retinal Vasculature after Intravitreal Conbercept versus Ranibizumab for Retinopathy of Prematurity
by: Enzhong Jin, et al.
Published: (2019-01-01)

Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
by: Robert B. Garoon, et al.
Published: (2016-01-01)

Intravitreal conbercept injection for neovascular age-related macular degeneration
by: Bing-Hui Wu, et al.
Published: (2019-02-01)

Eye surface changes of diffuse diabetic macular edema treated by intravitreal injection of Conbercept
by: Yi Shao*, et al.
Published: (2021-01-01)

The Efficacy of Intravitreal Conbercept for Chronic Central Serous Chorioretinopathy
by: Jianbo Mao, et al.
Published: (2019-01-01)

Intravitreal anti-VEGF therapy as an adjunct to laser photocoagulation for severe aggressive posterior retinopathy of prematurity
by: Sengul Ozdek, et al.
Published: (2013-01-01)

Bilateral Hypertensive Retinopathy Complicated with Retinal Neovascularization: Panretinal Photocoagulation or Intravitreal Anti-VEGF Treatment
by: Odysseas Georgiadis, et al.
Published: (2014-07-01)

Clinical study of Conbercept in patients with proliferative diabetic retinopathy undergoing vitrectomy
by: Shao-Hua Shi, et al.
Published: (2020-05-01)

Laser therapy versus intravitreal injection of anti-VEGF agents in monotherapy of ROP: a Meta-analysis
by: Shi-Dan Wang, et al.
Published: (2020-05-01)

Curative effect of intravitreal injection of conbercept on macular edema in different types of OCT diabetes mellitus
by: Han Ren, et al.
Published: (2019-07-01)

Clinical Observation of Phacoemulsification Combined with Intravitreal Injection of Conbercept in Cataract Patients with Diabetic Macular Edema
by: Jing Wang, et al.
Published: (2021-01-01)

Novel VEGF decoy receptor fusion protein conbercept targeting multiple VEGF isoforms provide remarkable anti-angiogenesis effect in vivo.
by: Qin Wang, et al.
Published: (2013-01-01)

Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab
by: Jiu-Ke Li, et al.
Published: (2015-12-01)

Meta-analysis of long-term efficacy of vitrectomy combined with anti-VEGF in the treatment of proliferative diabetic retinopathy
by: Wen-Qiang Hu, et al.
Published: (2021-06-01)

Comparison of curative effects of intravitreal injection of Ranibizumab and Conbercept in the treatment of diabetic macular edema
by: Yang Guo, et al.
Published: (2018-01-01)

Retrospective analysis of anti-VEGF intravitreal injection
by: Hai-Zhi Ma, et al.
Published: (2017-03-01)

Proteomic analysis of anti-angiogenic effects by conbercept in the mice with oxygen induced retinopathy
by: Ji Jin, et al.
Published: (2020-12-01)

Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy
by: Bing Li, et al.
Published: (2020-03-01)